Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
09/12/2019 - 4 minutes
CAR-T
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…
14/11/2019 - 2 minutes
First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors
The Belgian company Celyad has released the first interim clinical efficacy data for an off-the-shelf…
12/11/2019 - 2 minutes
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
27/09/2019 - 3 minutes
A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
10/09/2019 - 9 minutes
Manufacturing Delays Set Back Autolus’ CAR-T Programs by Five Months
The UK biotech Autolus’ shares have slumped as construction delays from a new manufacturing site…
12/08/2019 - 2 minutes
Will T Cells Cure Cancer Soon?
As an important part of the adaptive immune system, T cells play an essential role…
22/07/2019 - 9 minutes
Gamma Delta T Cells: A New Hope Against Cancer
A new wave of therapies based on a unique type of immune cells, called gamma…
11/06/2019 - 5 minutes
Highlights from European Biotech at ASCO 2019
European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research…
05/06/2019 - 5 minutes
Belgian and US Biotechs Team up to Reduce CAR T Side Effects
The diagnostics company Biocartis is collaborating with Kite Pharma to monitor the progress of CAR…
03/06/2019 - 3 minutes
Minicircle DNA: Can This Technology Change CAR-T Therapy For the Better?
In biotechnology, plasmids are commonly used as vectors for the replication and cloning of recombinant…
06/05/2019 - 7 minutes
Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma
Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a…
01/05/2019 - 3 minutes
